{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:09:48Z","timestamp":1747181388265,"version":"3.40.5"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>High-risk cytomegalovirus (CMV) and Epstein-Barr virus (EBV) mismatches (ie, seropositive donors to seronegative recipients) among kidney transplant recipients lead to increased healthcare utilization, inferior allograft outcomes, and high mortality. We assessed the interest among prospective kidney donor and recipient candidates to participate in kidney paired donation (KPD) for averting CMV\/EBV high-risk mismatches.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We surveyed 51 potential living donors and 102 kidney recipient candidates presenting for their evaluation visit at the University of Pittsburgh Medical Center between October 2022 and May 2023. We evaluated their general inclination toward KPD and their interest in KPD under various risk-benefit scenarios, particularly emphasizing the mitigation of high-risk mismatches associated with EBV and CMV. This was done using a 5-point Likert scale (1-low interest; 5-high interest) customized survey.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>There was high interest in KPD among both donor and recipient candidates (median score 4 versus 4; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.09). However, donor candidates had a lower interest in KPD if they were compatible with their intended recipient (median score 2 versus 4; <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>&lt;\u20050.001). Most donor (80.4%; N\u2005=\u200541) and recipient candidates (89.2%; N\u2005=\u200591) expressed a strong willingness to participate in KPD to prevent high-risk CMV and EBV mismatches, but this interest declined with longer transplant delays. Interest also varied on the basis of participants\u2019 income and employment status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Interest in KPD for avoiding CMV and EBV was high among both donor and recipient candidates. Additional research is required to assess the capacity and desirability for KPD expansion, particularly among ABO and HLA-compatible pairs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001737","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T05:00:13Z","timestamp":1732165213000},"page":"e1737","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mitigating High-risk EBV and CMV Through Kidney Paired Donation: A Survey of Potential Donor and Recipient Candidates"],"prefix":"10.1097","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7398-9853","authenticated-orcid":false,"given":"Arjun","family":"Kalaria","sequence":"first","affiliation":[{"name":"Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajil B.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA."},{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Sood","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of California, San Francisco, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Health and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry J.","family":"Morford","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnu","family":"Potluri","sequence":"additional","affiliation":[{"name":"Renal-Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F. P.","family":"Bridges","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4856-9242","authenticated-orcid":false,"given":"Chethan M.","family":"Puttarajappa","sequence":"additional","affiliation":[{"name":"Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA."},{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"R1-20250313","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/j.1600-6143.2010.03225.x","article-title":"Primary CMV infections are common in kidney transplant recipients after 6 months valganciclovir prophylaxis.","volume":"10","author":"Helantera","year":"2010","journal-title":"Am J Transplant"},{"key":"R2-20250313","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/ctr.12810","article-title":"Cytomegalovirus infection in high-risk kidney transplant recipients receiving thymoglobulin induction-a single-center experience.","volume":"30","author":"Puttarajappa","year":"2016","journal-title":"Clin Transplant"},{"key":"R3-20250313","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"R4-20250313","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ajt.15183","article-title":"Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: a paired kidney analysis.","volume":"19","author":"Leeaphorn","year":"2019","journal-title":"Am J Transplant"},{"key":"R5-20250313","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/TP.0000000000000641","article-title":"Impact of cytomegalovirus on long-term mortality and cancer risk after organ transplantation.","volume":"99","author":"Desai","year":"2015","journal-title":"Transplantation"},{"key":"R6-20250313","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.TP.0000055098.96022.F7","article-title":"Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.","volume":"75","author":"Shahinian","year":"2003","journal-title":"Transplantation"},{"key":"R7-20250313","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.","volume":"8","author":"McDonald","year":"2008","journal-title":"Am J Transplant"},{"key":"R8-20250313","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.ajkd.2011.07.015","article-title":"Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.","volume":"58","author":"Kasiske","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R9-20250313","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2018.06.009","article-title":"Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients.","volume":"94","author":"Francis","year":"2018","journal-title":"Kidney Int"},{"key":"R10-20250313","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.transproceed.2022.10.017","article-title":"Incidence of lymphoproliferative disorders after renal transplantation is down, but the poor prognosis remains. Multicenter 32-year cohort study.","volume":"54","author":"Franco","year":"2022","journal-title":"Transplant Proc"},{"key":"R11-20250313","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/ajt.16826","article-title":"Rethinking incompatibility in kidney transplantation.","volume":"22","author":"Jackson","year":"2021","journal-title":"Am J Transplant"},{"key":"R12-20250313","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/ajt.13218","article-title":"Equipoise: ethical, scientific, and clinical trial design considerations for compatible pair participation in kidney exchange programs.","volume":"15","author":"Cuffy","year":"2015","journal-title":"Am J Transplant"},{"key":"R13-20250313","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/TP.0000000000002947","article-title":"Ten years of kidney paired donation at mayo clinic: the benefits of incorporating ABO\/HLA compatible pairs.","volume":"104","author":"Basu","year":"2020","journal-title":"Transplantation"},{"key":"R14-20250313","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/TP.0b013e3181c626e1","article-title":"The altruistic unbalanced paired kidney exchange: proof of concept and survey of potential donor and recipient attitudes.","volume":"89","author":"Ratner","year":"2010","journal-title":"Transplantation"},{"key":"R15-20250313","doi-asserted-by":"crossref","first-page":"101317","DOI":"10.1016\/j.trim.2020.101317","article-title":"Improving HLA matching in living donor kidney transplantation using kidney paired exchange program.","volume":"62","author":"Tafulo","year":"2020","journal-title":"Transpl Immunol"},{"key":"R16-20250313","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/TP.0000000000001196","article-title":"Providing better-matched donors for HLA mismatched compatible pairs through kidney paired donation.","volume":"101","author":"Ferrari","year":"2017","journal-title":"Transplantation"},{"key":"R17-20250313","article-title":"Finding the best kidney transplant match."},{"key":"R18-20250313","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/TP.0000000000003887","article-title":"The clinical and economic benefit of CMV matching in kidney transplant: a decision analysis.","volume":"106","author":"Axelrod","year":"2022","journal-title":"Transplantation"},{"key":"R19-20250313","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","article-title":"Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition.","volume":"208","author":"Balfour","year":"2013","journal-title":"J Infect Dis"},{"key":"R20-20250313","doi-asserted-by":"crossref","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One"},{"key":"R21-20250313","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis.","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"R22-20250313","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/ajt.14195","article-title":"Transplant infectious diseases: a review of the scientific registry of transplant recipients published data.","volume":"17","author":"Kotton","year":"2017","journal-title":"Am J Transplant"},{"key":"R23-20250313","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/ajt.14275","article-title":"Reciprocity to increase participation of compatible living donor and recipient pairs in kidney paired donation.","volume":"17","author":"Gill","year":"2017","journal-title":"Am J Transplant"},{"key":"R24-20250313","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1600-6143.2007.01935.x","article-title":"Expanding kidney paired donation through participation by compatible pairs.","volume":"7","author":"Gentry","year":"2007","journal-title":"Am J Transplant"},{"key":"R25-20250313","first-page":"181","article-title":"Expanding the live kidney donor pool: ethical considerations regarding altruistic donors, paired and pooled programs.","volume":"9","author":"Patel","year":"2011","journal-title":"Exp Clin Transplant"},{"key":"R26-20250313","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12978","article-title":"Characteristics of compatible pair participants in kidney paired donation at a single center.","volume":"31","author":"Weng","year":"2017","journal-title":"Clin Transplant"},{"key":"R27-20250313","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1111\/ajt.16136","article-title":"The first increase in live kidney donation in the United States in 15 years.","volume":"20","author":"Al Ammary","year":"2020","journal-title":"Am J Transplant"},{"key":"R28-20250313","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11061620","article-title":"The impact of cold ischaemia time on outcomes of living donor kidney transplantation: a systematic review and meta-analysis.","volume":"11","author":"van de Laar","year":"2022","journal-title":"J Clin Med"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:02:22Z","timestamp":1741885342000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001737","relation":{},"ISSN":["2373-8731"],"issn-type":[{"type":"electronic","value":"2373-8731"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}